Infectious toxicities in patients treated with bispecific antibodies in multiple myeloma

被引：0
|
作者：
Saez, Adolfo [1 ]
Lopez-Munoz, Nieves [1 ]
Maria Sanchez-Pina, Jose [1 ]
Alonso, Rafael [1 ]
Cuellar, Clara [1 ]
Lazaro, Paula [1 ]
Jimenez Ubieto, Ana [1 ]
Calbacho, Maria [1 ]
Martinez Lopez, Joaquin [1 ]
机构：
[1] Hosp 12 Octubre, Madrid, Spain
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-113
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [31] The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies
    Swan, Dawn
    Routledge, David
    Harrison, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 488 - 506
  • [32] Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety
    Swan, Dawn
    Murphy, Philip
    Glavey, Siobhan
    Quinn, John
    CANCERS, 2023, 15 (06)
  • [33] Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy
    Wang, Moran
    Wang, Chaofan
    Deng, Jun
    Wang, Huafang
    Sun, Chunyan
    Luo, Shanshan
    Hu, Yu
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (06):
  • [34] Infectious Complications in Patients Treated with Idecabtagene Vicleucel for Relapsed and Refractory Multiple Myeloma
    Little, Jessica S.
    Shah, Parth
    Sperling, Adam S.
    Branagan, Andrew R.
    Nadeem, Omar
    Yee, Andrew J.
    Raje, Noopur S.
    Munshi, Nikhil C.
    Hammond, Sarah
    BLOOD, 2021, 138 : 3839 - +
  • [35] Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomib
    Zhao, Fang
    Yang, Bo
    Wang, Juan
    Zhang, Rui
    Liu, Jing
    Yin, Fenglei
    Xu, Weixing
    He, Chunyuan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1525 - 1531
  • [36] Infectious Complications during Treatment with Commercial CAR T-Cell Therapy and Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
    Jurgens, Eric M.
    Shekarkhand, Tala
    Farzana, Tasmin
    Rueda, Colin
    Nemirovsky, David
    Derkach, Andriy
    Firestone, Ross S.
    Nishimura, Noriko
    Miller, Kevin
    Costa, Bruno Almeida
    Nath, Karthik
    Rajeeve, Sridevi
    Lesokhin, Alexander M.
    Korde, Neha
    Tan, Carlyn Rose
    Hashmi, Hamza
    Hassoun, Hani
    Maclachlan, Kylee H.
    Shah, Urvi A.
    Hultcrantz, Malin
    Hamadeh, Issam S.
    Giralt, Sergio A.
    Chung, David J.
    Landau, Heather J.
    Scordo, Michael
    Shah, Gunjan L.
    Usmani, Saad Z.
    Mailankody, Sham
    Shahid, Zainab
    BLOOD, 2024, 144 : 6935 - 6936
  • [37] IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
    Lancman, Guido
    Parsa, Kian
    Kotlarz, Krzysztof
    Avery, Lisa
    Lurie, Alaina
    Lieberman-Cribbin, Alex
    Cho, Hearn Jay
    Parekh, Samir S.
    Richard, Shambavi
    Richter, Joshua
    Rodriguez, Cesar
    Rossi, Adriana
    Sanchez, Larysa J.
    Thibaud, Santiago
    Jagannath, Sundar
    Chari, Ajai
    BLOOD CANCER DISCOVERY, 2023, 4 (06): : 440 - 451
  • [38] The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT
    Hermann Einsele
    Leo Rasche
    Max S. Topp
    K. Martin Kortüm
    Johannes Duell
    Bone Marrow Transplantation, 2019, 54 : 721 - 726
  • [39] The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT
    Einsele, Hermann
    Rasche, Leo
    Topp, Max S.
    Kortuem, K. Martin
    Duell, Johannes
    BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) : 721 - 726
  • [40] INTERFERENCES IN THE SCREENING OF IRREGULAR ANTIBODIES IN 4 PATIENTS WITH MULTIPLE MYELOMA TREATED WITH DARATUMUMAB
    Ramirez Patricia, Garcia
    Montserrat, Olcoz
    Montserrat, Alvarellos
    Ma Cruz, Montoya
    Pamela, Millacoy
    Jose Maria, Arguinano
    Ma Piva, Sanchez
    Saioa, Zalba
    Ma Victoria, Aznar
    Ma Luisa, Antelo
    Itziar, Ezpeleta
    HAEMATOLOGICA, 2016, 101 : 275 - 276
12345